Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

NCT02873416 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Precision Cell Immunotherapy
Chemotherapy
Advanced Lung Cancer

Interventions

DRUG: Chemotherapy
BIOLOGICAL: Precision Cells

Sponsor

Ningbo Cancer Hospital